+ Watch ANGO
on My Watchlist
The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.
Provider of medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. Acquired RITA in 2007 and now has a diverse product line that includes radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. Advance guidence on 3Q sales growth of 14% missed wallstreets expectations and sent the stock down 37% for the day. BUY BUY BUY
You Go, Katwoman!pennysplants
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions